In this interesting article in the BMJ, the authors describe the burden of complex medicine on the patients and family members.
Although outcomes of treatment are routinely measured, assessing and documenting the burden of treatment could even become a key quality measure, say Mair and May, who have previously argued for “minimally disruptive medicine.”
At LION we are leading the way in minimally invasive, targeted treatments to minimise this disruption and reduce the side effects of the treatment itself.
A conversation with a University of Wisconsin-Madison neurosurgeon prompted two engineering researchers to challenge a commonly held idea about tumor ablation, and as a result, they’re now working to commercialize a new technology that could yield less invasive radiation therapies for cancer patients.
Follow this link to find out more
